News Snapshot:
Hong Kong’s IPO market achieves historic high in the first quarter of 2021, with funds raised reaching US$13.9bn, according to analysis by KPMG China. This continues Hong Kong’s strong IPO activity from the second half of last year, which saw Hong Kong and Mainland China achieve its most active IPO year (2020) since 2011, and further sees Hong Kong become the world’s leading biotech fundraising hub. According to KPMG’s 2021 Q1 review of Mainland China and Hong Kong IPO markets , total funds raised globally more than tripled compared with Q1 2020, with the US, Hong Kong and China’s A-share...
